Amex accepts Cardium's compliance plan
Cardium Therapeutics (San Diego) said that its exchange listing compliance plan which has been accepted by the NYSE Amex (formerly the American Stock Exchange). The company said the NYSE Amex notified Cardium that it had extended the time for compliance with the requirements of section 1003(a)(iv) from March 23 to June 27; and that the company would also need to regain compliance with section 1003(a)(ii) of the exchange's company guide regarding maintenance of stockholder's equity of at least $4 Million, which it would need to do by June 23, 2010.
The company will be subject to periodic review by the exchange staff during the extension period covered by the plan. Failure to make progress consistent with the plan or to regain compliance with the continued listing standards by the end of the applicable extension periods could result in the company's shares being delisted from the exchange.
New Vein Clinics of America opens in Ohio
IntegraMed America (Cleveland) said that its wholly-owned subsidiary, Vein Clinics of America (VCA), has opened its second office in Ohio, representing its 34th location in the U.S. Located in Beachwood, the new location offers the latest in vein disease diagnosis and treatment.
Sonja Stiller, MD, practicing physician at VCA's Beachwood office, said, "[We] are excited to be a part of the VCA team and look forward to offering patients in the greater Cleveland area the latest in minimally invasive techniques for diagnosing and treating their chronic vein problems. All procedures are performed in our state-of-the-art facility, requiring no hospitalization or surgery, allowing patients to be back on their feet the same day."
Study identifies genetic connection in stroke risk
Scientists have identified a previously unknown connection between two genetic variants and an increased risk of stroke, providing strong evidence for the existence of specific genes that help explain the genetic component of stroke. The research was funded by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (Bethesda, Maryland) and by several other NIH institutes and centers.
The analysis of more than 19,000 participants was published online on April 15 by the New England Journal of Medicine and will appear in print on April 23.
"This study, which integrates longstanding observational trials such as Framingham with cutting-edge genomic technologies, moves us closer to the era of personalized medicine," said NHLBI Director Elizabeth Nabel, MD "As we learn more about the role that an individual's unique genetic makeup plays in their overall health, we will ultimately be able to tailor care to better diagnose, prevent, and treat conditions such as stroke."
Stroke is the third-leading cause of death in the U.S. and causes serious long-term disabilities for many Americans.
Millstone to hold open house in Fall River
Millstone Medical Outsourcing (Fall River, Massachusetts) reported the official opening of the company's new facility in Fall River. Millstone will hold an open house on April 24, for customers, vendors, state and local dignitaries, and friends of the company.
"We are excited to add 30,000 square feet to our Fall River operations to meet customer demand for advanced inspection and clean room services," said CEO Christopher Ramsden. "The new facility is specifically designed to enable Millstone to scale with medical device manufacturers and solve specialized inspection, packaging, and distribution challenges."
The new center includes an advanced mechanical inspection area, a 5,000 square-foot clean room, and significant floor space for packaging. The inspection cell will feature optical comparators, coordinate measuring machines, vision systems, and micro-hites.